First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages e127-e128

  Wu, Hongyi ^a   Wang, Qibing ^a   Zhou, Jingmin ^a   Qian, Juying ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Stent thrombosis; Ticagrelor

Indexed keywords

ADENOSINE; CLOPIDOGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICAGRELOR; TICLOPIDINE;

ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; CASE REPORT; CHEMICALLY INDUCED; DRUG SUBSTITUTION; DYSPNEA; HUMAN; MALE; STENT; THROMBOSIS;

ADENOSINE; AGED; DRUG SUBSTITUTION; DYSPNEA; HUMANS; MALE; PURINERGIC P2Y RECEPTOR ANTAGONISTS; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 84908238249     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.216     Document Type: Article

References (10)

1. 2012 Writing Committee Members, H. Jneid, and J.L. Anderson 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 126 2012 875 910
2. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
3. S.S. Nijjer, J.E. Davies, and D.P. Francis Quantitative comparison of clopidogrel 600 mg, prasugrel and ticagrelor, against clopidogrel 300 mg on major adverse cardiovascular events and bleeding in coronary stenting: synthesis of CURRENT-OASIS-7, TRITON-TIMI-38 and PLATO Int J Cardiol 158 2012 181 185
4. P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
5. M. Gaubert, M. Laine, and T. Richard Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients Int J Cardiol 173 2014 120 121
6. P.A. Gurbel, K.P. Bliden, and K. Butler Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study Circulation 121 2010 1188 1199
7. D.J. Angiolillo, N. Curzen, and P. Gurbel Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: results of the SWAP-2 study (Switching Anti Platelet-2) J Am Coll Cardiol 63 2014 1500 1509
8. R.F. Storey, K.P. Bliden, and S.B. Patil Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study J Am Coll Cardiol 56 2010 185 193
9. R.F. Storey, R.C. Becker, and R.A. Harrington Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes Eur Heart J 32 2011 2945 2953
10. C. Patrono, C. Baigent, and J. Hirsh Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 2008 199S 233S